AQR Arbitrage’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,485,000
Closed -$14.9M 463
2024
Q4
$14.9M Buy
+1,485,000
New +$14.9M 0.33% 109

Other funds holding TDACU

AQR Arbitrage's TDACU Position: Q1 2025 in Review

AQR Arbitrage sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 1,485,000 shares — an estimated $14.9M sold.

AQR Arbitrage first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $14.9M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • AQR Arbitrage reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • AQR Arbitrage sold 1,485,000 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $14.9M.
  • AQR Arbitrage first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • AQR Arbitrage's Translational Development Acquisition Corp Units position peaked at $14.9M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on AQR Arbitrage's 13F filing for Q1 2025, filed 15 May 2025.